The Drug Safety Research Unit (DSRU) is an independent academic unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training Services for over 30 years.
In partnership with doctors in England, the DSRU, led by Director Professor Saad Shakir, aims to protect patients in primary and specialist care from unwanted adverse effects of newly marketed medicines using our unique methods of monitoring patients during the lifecycle of medicines.
The DSRU is co-ordinating a network of post-authorisation safety studies (PASS) on an antidiabetic drug, in collaboration with partner research centres in Italy (Messina), Germany (BiPs) and the Netherlands (PHARMO). The DSRU will conduct a Modified Prescription-Event Monitoring Study whilst the partner research centres will work with their local research database to answer the same research questions specified according to common aims and objectives. The data collection phase of the network of studies is now underway.View our latest news
The DSRU provide a range of training courses covering numerous topics within Pharmacovigilance (PV). One topic that is featured in many courses, due to its importance and relevance to all aspects of PV, is regulations. Two of our courses focus on regulations, one from an EU perspective, EU Regulations and Guidelines, and one from a Global […]View all our latest questions